Gino Santini

Gino Santini

Président chez COMPASS PATHWAYS PLC

Fortune : 4 M $ au 31/05/2026

69 ans
Health Technology
Commercial Services
Consumer Services

Profil

Gino Santini is currently Chairman at Lakefront Biotherapeutics since 2026, Chairman at Collegium Pharmaceutical, Inc. since 2012, Non Executive Chairman at Compass Pathways Plc since 2024, Director at ImClone LLC since 2008, Director at Artax Biopharma, Inc. since 2015, Director at Intarcia Therapeutics, Inc. since 2013, and Independent Director at Enalare Therapeutics, Inc. Former roles include Chairman at National Pharmaceutical Council, Chairman at AMAG Pharmaceuticals, Inc. from 2014 to 2020, Chairman at Noble of Indiana, Lead Independent Director at Intercept Pharmaceuticals, Inc. from 2018 to 2023, Independent Director at Inspiration Biopharmaceuticals, Inc., Independent Director at Horizon Therapeutics Ltd. (Ireland) from 2012 to 2023, Independent Director at Sorin SpA from 2012 to 2015, Independent Director at Vitae Pharmaceuticals LLC from 2015 to 2016, Director at Greater Indianapolis Chamber of Commerce, Inc., Director at United Way of Central Indiana, Inc., Director at Indiana Chamber of Commerce, Director at Finanziaria Saccarifera Italo Iberica SpA from 2013 to 2014, Independent Director at Horizon Pharma, Inc. from 2012 to 2014, Director at Allena Pharmaceuticals, Inc. from 2012 to 2022, Director at United Way of The Lewis & Clark, SVP-Corporate Strategy & Business Development at Eli Lilly & Co. from 2008 to 2010, General Manager at Eli Lilly y Cia.
de México SA de CV, and Advisor at Prime Movers Lab LLC.
Education includes an MBA from the University of Rochester Simon Business School conferred in 1983 and an undergraduate degree from Alma Mater Studiorum - Università di Bologna conferred in 1981.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
08/06/2026 112 483 ( 0,35% ) 4 M $ 31/05/2026
27/05/2026 0 ( -.--% ) - $ 31/05/2026

Postes actifs de Gino Santini

SociétésPosteDébut
COLLEGIUM PHARMACEUTICAL, INC. Président 15/05/2025
COMPASS PATHWAYS PLC Président 03/09/2024
LAKEFRONT BIOTHERAPEUTICS NV Président 28/04/2026
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 01/04/2015
Directeur/Membre du Conseil 21/11/2008

Anciens postes connus de Gino Santini

SociétésPosteFin
INTERCEPT PHARMACEUTICALS, INC. Directeur/Membre du Conseil 08/11/2023
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY Directeur/Membre du Conseil 06/10/2023
ALLENA PHARMACEUTICALS, INC. Directeur/Membre du Conseil 02/09/2022
░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Gino Santini

Formation de Gino Santini

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

65

Relations au 1er degré

27

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées27

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Commercial Services

Health Services

Commercial Services

Commercial Services

Health Technology

Commercial Services

Finance

Eli Lilly y CIA de México SA de CV

Health Technology

Health Technology

Consumer Services

United Way of The Lewis & Clark

Finance

Health Technology

Commercial Services

  1. Bourse
  2. Insiders
  3. Gino Santini
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT